patient
To sponsor this category, click here | subscribe to this category RSS

"I will never go away" a patient says but who set up this page and who was responsible for maintaining it ?

Monday, March 8th, 2010

Maybe it was the right hand not knowing what the left hand was doing although that is hard to believe because this page should have gone through some legal and regulatory sign off but like Mr Grant states “the damage is done”. An upset patient who has decided to challenge Sanofi on their side effects. Was she informed ?

Posted in: DTC, Social Media | 0 Comments »
Read the full story

HER2 Confusion

Friday, February 26th, 2010

For years now, drug companies and journalists have been touted the new era of personalized medicine. This is one of those things that always seems to be arriving, but is taking its time getting here. The industry has sunk a huge pile of money into biomarker research, and it’s safe to say that it hasn’t paid off yet – although, at the same time, one still has to think that it should, eventually

Posted in: In the Pipeline | 0 Comments »
Read the full story

Treating patients means more than writing an Rx

Wednesday, January 13th, 2010

Type 2 diabetes, often called non-insulin dependent diabetes, is the most common form of diabetes, affecting 90% – 95% of the 21 million people with diabetes. The rate of diabetes is rising because most Americans don’t get enough exercise and eat a diet too rich in fat and calories.

Posted in: DTC | 0 Comments »
Read the full story

Will Patients Find Value in Discussions with Pharma Marketers on Social Media Sites?

Tuesday, December 15th, 2009

At the November, 2009, BDI Forum in New York City (“Healthcare Social Communications Leadership Forum Breakfast”), a question from the audience to a panel I was part of got to the core of the value of pharma to online patient communities.

Posted in: Web Marketing | 0 Comments »
Read the full story
No Image

Performance-based Pricing in Patient Recruitment

Tuesday, December 1st, 2009

Date Posted: 12/01/2009 Size: 14.4MB Length: 00:14:04 Thought Leader: Richard Malcolm Ph.D., CEO, AcurianDr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.

Play
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Posted in: Podcasts | 0 Comments »
Read the full story

Friday ramblings

Friday, November 27th, 2009

One thing I learned while marketing supplements in the late 90’s (when the supplement market was over $1 billion) was people will take anything that promises good health in a bottle, often to compensate for bad habits.

Posted in: DTC | 0 Comments »
Read the full story

We asked and Physicians sounded off

Monday, October 26th, 2009

The goal of this research was to determine how physicians felt about medical information on health website. While I heard that they were supportive they also voiced concerns about misinformation and online tools that patients often use for self-diagnosis

Posted in: DTC | 0 Comments »
Read the full story

Along the way something happened

Thursday, September 24th, 2009

I was not in DTC marketing in the 90’s but often heard stories about the “good old days”. Back then people at Lilly received 20-40% bonuses and they were proud to be working in Indiana for Lilly. In the late 90’s and early in the new millennium however Wall Street’s motto became “instant gratification takes too long”

Posted in: DTC | 0 Comments »
Read the full story

Alexion – PNH threatening

Friday, September 18th, 2009

PNH ??? progressive, life threatening… and in your practice

Posted in: Pharma Ads | 0 Comments »
Read the full story

Crestor – little secret

Thursday, September 17th, 2009

“My diabetes and high cholesterol share an ugly little secret.” Diabetes and high cholesterol increase the risk of plaque buildup in arteries. That's why it's so important to manage your cholesterol. Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease.

Posted in: Pharma Ads | 0 Comments »
Read the full story
« Older Entries